Federal award
PHARMALUCENCE, INC.
W91YU011P0436
Contract
Obligated and Ceiling
- Obligated (net)
- $55,710.59
- Ceiling (potential value, not spending)
- —
- Current value
- —
- Gross positive obligations
- $156,825.67
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- PHARMALUCENCE, INC. · VFG7FHXXAMN3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SUN PHARMACEUTICAL INDUSTRIES LIMITED · K1LMDLNFJX45
- Awarding agency
- Department of War · sub-agency 2100 · office W81K04
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W91YU011P0436
- Award type code
- B
- Actions
- 12 · Jun 22, 2011 to Feb 28, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 28, 2017 | FY2017 | P00012 | K | −$44,259.00 | — |
| Sep 28, 2016 | FY2016 | P00011 | K | −$12,794.00 | — |
| Dec 9, 2014 | FY2015 | P00010 | D | −$28,842.33 | — |
| Oct 20, 2014 | FY2015 | P00009 | C | $69,602.92 | — |
| Sep 19, 2014 | FY2014 | P00008 | G | $0.00 | — |
| Apr 22, 2014 | FY2014 | P00006 | G | $0.00 | — |
| Sep 28, 2012 | FY2012 | P00005 | D | −$15,219.75 | — |
| Sep 21, 2012 | FY2012 | P00004 | M | $0.00 | — |
| Sep 18, 2012 | FY2012 | P00003 | D | $0.00 | — |
| Sep 11, 2012 | FY2012 | P00002 | G | $0.00 | — |
| Jan 6, 2012 | FY2012 | P00001 | C | $44,259.00 | — |
| Jun 22, 2011 | FY2011 | 0 | — | $42,963.75 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.